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O R I G I N A L  R E S E A R C H
Abstract: Magnetic resonance imaging (MRI) findings are reported from 15 individuals in
an Arab–Israeli community who were diagnosed with Alzheimer’s disease (AD). The
quantitative parameters that were used for MRI analyses included gradings (0–3) and linear
measurements of different brain structures. Generalized tissue loss was assessed by combined
measurements of the ventricles (ventricular score, VS) and sulcal grading and width (SG, SW,
respectively). Loss of brain tissue in specific regions of interest, eg, temporal lobes, basal
ganglia, and midbrain, was evaluated by precise measurements. We observed abnormal tissue
characteristics, expressed as high intensity foci in white matter on T2W sequences, as well as
tissue loss, both generalized and focal. Most notable were changes involving the head of the
caudate nuclei, the midbrain, and to a lesser degree, medial temporal structures.
Keywords: magnetic resonance imaging, linear measures, brain structure, Alzheimer’s disease,
Arab population, Wadi-Ara, Israel
Introduction
The clinical diagnosis of Alzheimer’s disease (AD) remains problematic, as it is
largely based on the exclusion of other diseases. In particular, it is difficult to detect
AD in its early stages and discriminate it from other similar mental disorders (Winblad
et al 1986). Different diagnostic approaches, ie, positron emission tomography (PET),
single photon emission computed tomography (SPECT), neuropsychology,
neurogenetics, and electrophysiology have not yet provided definitive differential
features. Therefore, a reliable diagnostic method is needed for precise diagnosis
without invasive techniques (particularly at the onset of AD) (Dickerson et al 2001;
Killiany et al 2002; Koga et al 2002; Kantarci and Jack 2003). Structural neuroimaging
techniques such as magnetic resonance imaging (MRI) have played an important
role in the initial evaluation of dementia, especially for ruling out potentially treatable
etiologies. Findings such as ventricular enlargement, prominence of sulci, and cerebral
white matter areas of increased T2-weighted signal intensity on MRI have been
correlated with age, dementia of Alzheimer’s type, prior stroke, and hypertension
(Longstreth et al 1996; Yue et al 1997; Wahlund et al 2001; Hampel et al 2002; Teipel
et al 2002; Bronge 2003; de Leeuw et al 2004; Jack et al 2004). Volumetric, plani-
metric, and simple cross-sectional linear and area measurements of brain structures
seem to improve early diagnosis of AD (Frisoni et al 1996; Pucci et al 1996; Dickerson
et al 2001; Killiany et al 2002; Koga et al 2002; Kantarci and Jack 2003).
In the present study, we used a simple computerized linear MRI-based method of
measurement for evaluating the presence of AD, taking into consideration its
reproducibility, accuracy, and efficiency, as well as its excellent intraobserver
reliability. In contrast to volumetric measurement methods, which are very time-
consuming, the linear MRI method has easy applicability for almost all brain
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structures. Additionally, linear-based measures are less
constrained than volumetric measures in the assessment of
subcortical nuclei and limbic structures, such as the
hippocampus and parahippocampal gyrus, because of the
anatomical features of these structures (Frisoni et al 1996;
Pucci et al 1998; Whalley and Wardlaw 2001).
The Arab–Israeli community of the rural area of Wadi
Ara is unique with respect to having high rates of dementia
of Alzheimer’s type (DAT) (Bowirrat et al 2001, 2002). The
high prevalence of DAT in this population was not explained
by ApoE-ε4 allele, since this population was found to have
the lowest frequency of this allele ever recorded (Bowirrat
et al 2000). The ApoE distributions in this small group was
as follows: six patients (6/15) were found to carry the ApoE
allele (all heterozygous) = ApoE-ε4/ε3, and nine patients
(9/15) were found to carry ApoE allele = ApoE-ε3/ε3.
Although those patients fulfilled DSM-IV1 and NINCDS-
ADRDA2 criteria for AD (McKhann et al 1984; APA 1994),
autopsy confirmation is lacking, and because of local
tradition it is unlikely to become available.
The aim of the present study was to use structural MRI
to characterize the brains of patients with AD, using
quantitative parameters enabling description of findings in
a standardized approach (Reider-Groswasser 1997; Heinik
et al 2000; Kantarci and Jack 2003). Linear MRI-based
measurements (which correspond to the maximum distance
between two end points from side to side) as well as semi-
quantitative gradings of the findings in this population
are detailed. These data delineate the morphometric
characteristics of Wadi Ara AD patients.
Methods
Patient characteristics
In our previous studies (Bowirrat et al 2001, 2002), we
identified a high prevalence of DAT among the elderly
population of Wadi Ara, Israel. Many individuals had mild
cognitive deficits, although they did not fulfill DSM-IV
criteria for dementia (APA 1994). In a follow-up study we
identified several cases (n = 24) who progressed to become
demented. From among these 24 cases, 15 (8 males) were
selected for MRI studies. We excluded cases with significant
other diseases, such as cancer, severe cardiac disease, and
arthritis, because these disorders might either affect the
patients’ transport or complicate the analysis of the results.
The mean age of the 15 cases was 76 years (range 74–78
years). Their mean Mini-Mental State Examination (MMSE)
score (Folstein et al 1975) was 16.2 (SD ± 4).
MRI acquisition
The MRI study was conducted by a team of neurologists
and radiologists at Tel-Aviv Medical Center, Israel and
Boston University Medical School, USA, who arrived at a
consensus regarding the MRI findings. The MRI scans were
acquired on a GE Signa 1.5 Tesla scanner. Although some
patients were restless and often needed sedation, the studies
were not performed under generalized anesthesia. Scans that
contained movement artifacts were not included. For all
patients, at least three sequences were obtained: FLAIR,
FSET2, and SET1. Axial slices were obtained parallel to a
cut passing through the line connecting the anterior and the
posterior commissures (AC-PC line). Their thickness was
3.5 mm, with 1 mm between adjacent cuts. Coronal cuts were
perpendicular to the AC-PC line. The thickness of the cuts
was 3.0 mm, and the distance between adjacent cuts was
0.8 mm. Sagittal cuts were performed through planes parallel
to the midline. Their thickness was 5 mm with a 2 mm gap
between adjacent cuts. Field of view for the axial and sagittal
cuts was 24 cm × 24 cm and 24 cm × 18 cm, and for the
coronal cuts 24 cm × 18 cm.
MRI analyses
The presence of focal lesions in the brain was documented
as either hyperintense T2 FLAIR lesions, or infarcts (either
cortical or lacunar). The hyperintense T2 signals were graded
into subgroups WMG1 (graded from 0 to 9) and WMG2
(graded from 0 to 3) according to procedures described by
Manolio et al (1994), Bryan et al (1994), and Longstreth et
al (1996) for grading white matter changes (WMG) (graded
from 0 to 9) (Table 1).
Regarding the linear measurements and semiquantitative
gradings, axial, coronal, and sagittal MRI cuts were
employed. Axial cuts, performed with FLAIR sequence,
were used for the linear measurements; FSE T2 sequences
were used for coronal measurements; and SET1 sagittal cuts
were used for the sagittal measurements. The measurements
were performed on the films and adjusted to the ruler that
appeared on each cut. Twenty-three landmarks for
performing the measurements (numbered sequentially by
subscripts) are summarized in Table 1 and detailed as
follows:
BCD1. Bicaudate distance. This is the width of the left
and right frontal horns including the septum pellucidum,
measured on an axial cut showing the lower part of the
frontal horns, just in front of the foramen of Monro (Hughes
and Gado 1981). This measurement is also included in
CVI-2 and VS (see below).
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CCD2. Anteroposterior diameter of the genu of the
corpus callosum. This measure was taken from a sagittal
cut along a horizontal line passing between the inner
maximal concavity of the genu of the corpus callosum to its
outer maximal convexity.
CCH3. Corpus callosum height. This is the height of
corpus callosum on a coronal cut passing at the level of the
posterior part of the suprasellar cistern and the clivus. The
measurement was performed on a cut showing the posterior
part of the supracellar cistern, usually one cut behind the
one showing the optic chiasm, in the midline, from the upper
edge of the septum pellucidum to the highest point of the
corpus callosum.
CH-H.F4. Choroidal-hippocampal fissure grading (right,
left). 0 = no enlargement; 1 = mild enlargement (about pencil
line width); 2 = moderately enlarged (2–3 mm in antero-
posterior width); 3 = width exceeds 3 mm. Grading was
performed for the left and the right sides.
CMD5. Cella media distance. This was measured as the
minimal distance between the bodies of the lateral ventricles.
It was measured usually at a cut clearly showing the “waist”
of the bodies of the lateral ventricles, which is at the second
cut above the cut showing the internal cerebral veins. This
measurement is included in VS (see below).
CVI-26. Cerebroventricular index. This is the BCD
divided by the brain’s width at the same level.
HH7. Hippocampal height (right, left). This measurement
was performed on a T2 coronal cut (the third cut posterior
to the cut on which the basilar artery is seen). The
measurement is from the maximal convexity of the lower
border of the hippocampus to the lower border of the
adjacent temporal horn. To the best of our knowledge, this
measurement has not been defined previously.
IPD8. Interparietal distance. This measurement was
performed on the axial cut at the level of the bodies of the
lateral ventricles and on the same cut on which CMD was
measured. It is measured from outer to outer margins of the
brain at its largest parietal distance.
IUD9. Interuncal distance. This measurement was
performed both on axial and coronal planes. The distance
was measured between maximal convexities of the unci on
the cut in which the optic chiasm was seen in the suprasellar
cistern on an axial cut, and on the cut just posterior to the
one showing the optic chiasm on the coronal cut.
MBW, L-L10. Midbrain’s maximal latero-lateral width.
This measurement was performed on an axial cut across
the midbrain at its largest width.
MD11. Midbrain’s anteroposterior diameter. This was
measured on the sagittal plane along a line drawn from the
Table 1 List of 23 measurement landmarks with related references. The landmarks are listed alphabetically and denoted
sequentially by subscripts.
Abbreviation Meaning References
BCD1 Bicaudate distance Hughes et al 1981; Reider-Groswasser et al 1993
CCD2 Anteroposterior diameter of the genu of the corpus callosum Laissy et al 1993; Reider-Groswasser et al 1997
CCH3 Corpus callosum height
CH-H.F4 Choroidal-hippocampal fissure grading (right, left) George et al 1990
CMD5 Cella media distance Gyldensted et al 1976; Reider-Groswasser et al 1997
CVI-26 Cerebroventricular index 2 Hahn et al 1976; Heinik et al 2000
HH7 Hippocampal height (right, left)
IPD8 Interparietal distance
IUD9 Interuncal distance Dahlbeck et al 1991; Heinik et al 2000
MBW,L-L10 Midbrain maximal latero-lateral width Reider-Groswasser et al 2002
MD11 Midbrain anteroposterior diameter Raininko et al 1994; Reider-Groswasser et al 1997
MD-C12 Midbrain length at the center Schrag et al 2000; Warmuth-Metz et al 2001
MDL13 Midbrain length (right, left) Doraiswamy et al 1992
PD14 Anteroposterior diameter of the pons Raininko et al 1994; Reider-Groswasser et al 1997
SCD15 Septum-caudate distance Gyldensted et al 1976; Reider-Groswasser et al 1997
SG16 Sulcal width grading Furman 2000
SW17 Sulcal width Gyldensted 1976; Furman 2000
TH, a-p18 Temporal horn, anteroposterior diameter Heinik et al 2000; Reider-Groswasser et al 2002
TH, l-l19 Temporal horn, latero-lateral diameter (right, left)
VS20 Ventricular score Hughes et al 1981; Reider-Groswasser et al 1993
WMG21 White matter changes grading Manolio et al 1994; Longstreth et al 1996
3VW22 Third ventricle width Reider-Groswasser et al 1997
4VD23 Fourth ventricle anteroposterior diameter Raininko et al 1994; Reider-Groswasser et al 1997
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highest point of the pons to the posterior end of the tectum
between the superior and inferior colliculi. The distance is
from the intersection of this line with the midbrain to the
posterior end on the tectum.
MD-C12. Midbrain length at the center. This
measurement was performed on an axial cut at the center of
the midbrain from the most posterior point of the
interpeduncular cistern to the posterior border on the tectum
in the center.
MDL13. Midbrain length (right, left). This measurement
was performed on an axial cut from the center of the
posterior border of the tectum along a line passing laterally
to the aqueduct of Sylvius to a point intersecting with the
crus cerebri on the left and on the right.
PD14. Anteroposterior diameter of the pons. The
measurement was performed on the midsagittal cut along a
line that passes between the maximal convexity of the pons
to the fastigium. The posterior border of the pons is at the
intersection of this line.
SCD15. Septum-caudate distance. This was measured on
an axial cut from the maximal convexity of the head of the
caudate to the medial and anterior border of the frontal horn
on the left and the right sides.
SG16. Sulcal width grading. A scale from 0 to 3 was
used to measure enlargement of sulci: 0 = no enlargement;
1 = mild enlargement; 2 = moderately enlarged sulci (when
four or more sulci are widened above the ventricles, and
when there is widening of the interhemispheric fissure in
its anterior part); and 3 = severe enlargement (widening of
the entire hemispheric fissure).
SW17. Sulcal width. This is the mean value of the sum of
the four largest sulci measured at a high convexity cut
(typically the third cut above the ventricular bodies).
TH, a-p18. Temporal horn, anteroposterior diameter. This
measure was performed on an axial plane on the cut which
shows the optic chiasm in the suprasellar cistern. It is
measured from the maximal convexity of the posterior
border along a straight line to the anterior border of the
horn. This measurement was performed for the left and the
right sides.
TH, l-l19. Temporal horn, latero-lateral diameter (right,
left). This measurement was performed on the coronal view
on the cut suitable for the measurement of CCH. This cut is
usually just one cut posterior to the cut showing the optic
chiasm. The measurement was performed along a horizontal
line passing at the largest latero-lateral width of the
temporal horns.
VS20. Ventricular score. This is a calculated value, which
is the sum of SCD on the left and on the right sides, the
BCD, the third ventricle, and the CMD divided by the
widest width of the brain on the cut showing the lateral
ventricles, IPD.
WMG21. White matter changes grading. Grades ranged
from 0 to 9 as suggested by Manolio (1994) and Longstreth
(1996): 0 = no white matter changes; 1 = discontinuous
periventricular rim with minimal dots of subcortical disease;
2 = thin, continuous periventricular rim with a few patches
of subcortical disease; 3 = thicker, continuous periventricular
rim with scattered patches of subcortical disease; 4 = thicker,
shaggier periventricular rim with mild subcortical disease,
and may have minimal confluent periventricular lesions;
5 = mild periventricular confluence surrounding the frontal
and occipital horns; 6 = moderate periventricular confluence
surrounding the frontal and occipital horns;
7 = periventricular confluence with moderate involvement
of the centrum semiovale; and 8 = periventricular confluence
Figure 1 An 80-year-old male with dementia of the Alzheimer’s type. Axial
flair cut showing hyperintense signal and lacunar infarcts (black arrow) in the
periventricular white matter. Grading of white matter changes according to
Manolio et al (1994) and Longstreth et al (1996) –8/9.
B 
Neuropsychiatric Disease and Treatment 2005:1(1) 81
MRI parameters of Alzheimer’s disease
Tables 3, 4, and 5 show linear measurements in
millimeters performed on axial, coronal, and sagittal MRI
cuts, respectively. The measures indicate generalized tissue
loss in the AD patients, as reflected by ventricular score (VS),
cerebroventricular index 2 (CVI-2), and ventricle widths
(3VW and 4VW). Additionally, midbrain lengths (MDL) on
the right and left sides were small, as were bicaudate
measures (BCD). Additionally, there was a gender difference
in bicaudate distance (BCD), with females showing
significantly smaller values than males (p < 0.03) (Table 3).
involving most of the centrum semiovale. Cases with
findings more remarkable than grade 8 were scored 9.
3VW22. Third ventricle width. This was measured at the
axial cut best showing the third ventricle. The width was
measured at the junction of middle and posterior thirds of
the ventricle.
4VD23. Fourth ventricle anteroposterior diameter. This
was measured on the midsagittal cut along the line on which
the PD was measured. 4VD is the distance from the anterior
border of this line to the fastigium.
Results
All 15 patients had hyperintense T2 and FLAIR signals in
the white matter, mainly adjacent to the lateral ventricles
(Figure 1). Lacunar infarcts were found in 4/15 (26%) of
the patients. Cortical infarcts were found only in 1/15
patients (6.5%) (Figures 1 and 2).
Correlations between the sizes of various structures, and
their p-values (when significant), are detailed in Table 2.
Table 2 shows correlation coefficients (r) obtained for the
linear measures of specific brain structures (with significant
p-values). Significant correlations were found between the
following pairs of measures: the heights of the right and the
left hippocampus (Rt HH–Lt HH); the cerebroventricular
index 2 and bicaudate distance (CVI-2–BCD); the right
temporal horn and left (as well as right) hippocampus (Rt
TH–Lt HH, and Rt TH–Rt HH); the right and left temporal
horns, in anterior-posterior and in latero-lateral dimensions
(Rt TH–Lt TH, in all directions); and midbrain lengths at
its center and anterioposterior locations (MD-C–MD).
Table 2 Brain structures and correlation coefficient (r) and
significant p-values
Correlation coefficient (r) and
significant p-value
Brain structures r p
3VW – CCH –0.45
3VW – CCD –0.51
PD – CCH 0.5
CVI-2 – CCH –0.64
Rt HH – Lt HH 0.82 0.01
Rt HH – Rt TH –0.56
CVI-2 – BCD 0.95 0.006
IUD – CCH –0.5
Rt TH, a-p – Lt HH 0.78 0.001
Rt TH, a-p – Rt HH 0.9 0.0008
Rt TH, a-p – Lt TH, a-p 0.96 0.005
Rt TH, a-p – Lt TH l-l 0.55 0.01
MD-C– MD 0.75 0.002
SW-SG 0.65
Abbreviations: Rt, right; Lt, left; see text for brain structures.
Table 3 Linear measurements in mm, performed on axial MRI
cuts
Imaging parameter Mean SD
Lt SCD 9.2 1.7
Rt SCD 8.8 2.3
BCDa 20.3 3.1
3VW 8.1 1.4
CMD 30.1 5.8
IPD 125.7 4.1
VS 61 9.8
CVI-2 17.8 2.6
IUD 27.5 3.8
Lt TH a-p 5.1 3.1
Rt TH a-p 6.3 5.4
Lt MDL 26 2.3
Rt MDL 26.1 2.2
MD-W 34.1 3.2
MD-C 16.6 2.5
SW 5.1 1.7
a BCD, female and male mean values: 18.5 and 21.8, respectively, p < 0.03.
Abbreviations: MRI, magnetic resonance imaging; see text for imaging
parameters.
Figure 2 A 77-year-old woman with dementia of the Alzheimer type. Axial flair
cut showing hyperintense foci and a small cortical infarct in the left posterior
parietal lobe (black arrow). Note the widening of the left occipital horn.
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larger), senile plaques, and neurofibrillary tangles were seen
(Snowdon et al 1997). Fifteen of the patients had one or
two lacunar infarcts in the basal ganglia, thalamus, or deep
white matter. These findings suggest that cerebrovascular
disease may play an important role in determining the
presence and severity of the clinical symptoms of AD.
Of interest, we observed significant differences between
the genders in the size of bicaudate distance (BCD)
(Table 3). Whether this finding is related to the degenerative
brain process or to normal differences between genders
cannot be elucidated from this study, since we did not scan
normal age-matched controls. However, the significant
changes involve selective parameters only, and further
clarification would be valuable in future studies.
Imaging of the brain for delineation of tissue loss and
structural changes, and for the assessment of its function
and metabolic alterations, is widely used in patients with
dementia (Englund et al 1988; Aliev et al 2002; Bronge
2002; Hogervorst et al 2002; Bronge and Wahlund 2003).
Additionally, the studies of Jack et al (2003, 2004) open a
new opportunity for the use of volumetric and segmentation
techniques as valuable methods for evaluating disease
progression as well as the efficacy of clinical trials. In cases
where patients cannot be adequately sedated for more
complicated studies, however, the simplicity of linear
measurements may contribute to diagnostic accuracy and
enable repeated measurement and reassessments of
parameters in an easy fashion. Here, we successfully used
linear measurements for characterizing patterns of tissue
loss in AD.
In the present study, positive correlations were found
between white matter changes as reflected by corpus
callosum parameters (CCH, CCD) and some of the other
parameters (Table 2). A lack of statistical significance for
these correlations may be attributed to the small size of the
group examined. Even so, the positive findings support those
of Hampel et al (2002), who reported on corpus callosum
atrophy in AD patients and stressed that mainly the splenium
and the body of the corpus callosum were affected. The
presence of white matter changes in an elderly population
in general, and in AD in particular as seen in our study, is
also evident from other studies (Englund et al 1988; Tanabe
et al 1997; Bronge 2002; Hampel et al 2002; Hogervorst et
al 2002; Koga et al 2002; Bronge and Wahlund 2003; de
Leeuw et al 2004). The pathogenesis of these changes is
probably multifactorial and poorly understood, and recent
studies using diffusion tensor imaging suggest that it may
be secondary to Wallerian degeneration of fiber tracts due
Table 4 Linear measurements in mm, performed on coronal
MRI cuts
Imaging parameter Mean SD
HH Lt 7.4 0.9
HH Rt 7.4 1.2
TH, l-l, Lt 5.2 2.0
TH, l-l, Rt 5.5 5.2
CCH 3.4 0.5
Table 5 Linear measurements in mm, performed on sagittal
MRI cuts
Imaging parameter Mean SD
MD 16.1 2.5
PD 21.7 2.7
4VD 11.2 0. 9
CCD 10.6 3.2
Discussion
The present study, which involves a group of unique AD
patients, is mainly descriptive. We used a simple linear MRI-
based measurement method for evaluating brain changes
accompanying AD in an elderly Arab population in Israel.
Because our results are derived from a small sample size of
15 patients, the utility of linear measurements cannot be
assessed completely. Nonetheless, our findings confirm the
usefulness of this straightforward and quick approach for
characterizing patterns of tissue loss in dementia.
Additionally, results of our study are in an agreement with
the findings previously reported by Brinkman et al (1981),
Wood and Bigler (1995), and Heinik and colleagues (2000)
indicating generalized brain tissue loss (reflected by
increased ventricular size and sulcal width), hyperintense
foci in the white matter changes (mainly periventricular),
and the involvement of the caudate nuclei and midbrain.
The basal ganglia – including the caudate nucleus – are
known to be affected by neurological disorders such as
Parkinson’s disease, progressive supranuclear palsy,
Huntington’s disease, and traumatic brain injury (Cummings
1990; Reider-Groswasser 1997; Heinik et al 2000).
Additionally, the caudate plays an important role in
cognition, and caudate pathology has been shown to
adversely affect cognitive abilities (Cummings 1990; Heinik
et al 2000). Involvement of the basal ganglia, including the
caudate nucleus, in AD patients was especially convincing
in a study by Snowdon et al (1997). The principal aim of
that study was to determine the relationship of brain
infarction to the clinical expression of AD. Of 102
participants who later died, 61 met the neuropathologic
criteria of AD. At autopsy, lacunar infarcts (1.5 cm and
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to neuronal loss in cortical association areas (Bozalli et al
2002; Hampel et al 2002). The vascular abnormalities in
AD could reflect on the pathogenesis of the disease and be
related to ApoE status (Matsubayashi et al 1992; Kuller et
al 1998; Shi et al 2000; Bronge 2002; Korczyn and Chapman
2003). However, our AD group is peculiar because of having
marked white matter changes and practically no ApoE-ε4
haplotypes (Bowirrat at el 2000). In these cases, oxidative
stress and perfusion injury may underlie the white matter
lesions (Aliev et al 2002; Eckert et al 2003; Barnham et al
2004). These findings may indicate that, in fact, several
subjects actually suffer from mixed dementia rather than
pure AD (Korczyn 2002). The importance of the white
matter changes as factors that induce cognitive changes has
been stressed in the volumetric MRI study of Koga et al
(2002).
The generalized tissue loss in our patients is reflected
by ventricular score (VS) and cerebroventricular index 2
(CVI-2) (means of 61% and 17.8%, respectively). The
findings are close to the values documented on a
computerized tomography (CT) scan study of patients with
AD with a mean age of 78 years (means of 62.99% and
17.6%) (Heinik et al 2000) (Tables 1, 3). These close results
reflect on the high validity and good reproducibility of the
measurements. Also, the significant correlation (r = 0.75)
between the measurements of the midbrain performed on
axial and sagittal planes (MD-C and MD) reflect the
accuracy of the measures. The good correlation between
grading and measurements (sulcal grade and sulcal width,
r = 0.65) confirms the usefulness of a semiquantitative
approach for standardized imaging studies. This was also
found in a previous study assessing tissue loss in patients
with post-traumatic head injury (Reider-Groswasser et al
2002).
The medial temporal tissue loss as reflected by the
interuncal distance (IUD) is also very close to the values
reported by Heinik et al (2000). It is 27.87 mm in the study
of Heinik et al (2000) and 27.47 (SD ± 3.8) in our present
MRI study (Table 3). The bicaudate distance (BCD) and
the CVI-2 correlated significantly with the clock drawing
test in the study of Heinik et al (2000), and since the CVI-2
values are so close in both studies, 17.6 (SD ± 3.0 ) and 17.8
(SD ± 2.6) respectively (as mentioned above, Table 3), it
supports the likelihood of caudate involvement in the AD
population of Wadi Ara.
The correlations of medial temporal tissue loss (Table 2)
reflect their association (TH, HH, IUD). Significant p-values
were only seen between the TH on the left and on the right
(p = 0.005), and between their axial and coronal measures
(p = 0.001). The correlation between hippocampal height
(HH) and temporal horn (TH) as shown in Table 2 also were
statistically significant (p < 0.001), and should be further
assessed in larger series. These results show the usefulness
of HH as a parameter for assessment of medial temporal
structures. Our data also confirm the major morphologic
changes in medial temporal parameters that have been
described by others to occur in the course of AD (Frisoni et
al 1996; Jack et al 2004).
In the present study, the mean value of the antero-
posterior diameter of the midbrain as measured in the axial
plane, midbrain length-center (MD-C), is close to the
measurement that was performed on the sagittal plane –
midbrain anteroposterior diameter (MD) (16.64 and
16.12 mm, respectively) (Tables 3, 5). The decreased
midbrain diameter on the axial planes has been described
in progressive supranuclear palsy (Schrag et al 2000;
Warmuth-Metz et al 2001), and to the best of our knowledge,
it has not yet been described in AD. This parameter should
be correlated with clinical findings and reassessed in a larger
AD population.
Conclusions
In the present study, we used a simple linear MRI-based
measurements method for evaluating 15 patients with DAT
in an elderly Arab population in Israel. We found altered
tissue characteristics, expressed as high intensity foci in
white matter on T2W sequences, and tissue loss, both
generalized and local (involving the head of the caudate,
the midbrain, and to a lesser degree medial temporal
structures). The significance of our findings, as well as the
additional information derived from correlations among the
different parameters, suggest that these patients are a unique
group with distinct imaging features, perhaps related to their
low frequency of ApoE-ε4 allele. Whatever the underlying
mechanisms, results of these investigative analyses warrant
consideration in other populations of elderly people. Such
patterns may provide clues about the pathophysiology of
structural brain changes in the elderly.
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